Vancouver, WA – March 2026 – Inovia Vein is pleased to announce that Dr. Lauren Wikholm, Director of Inovia Vein in Vancouver, Washington, presented new clinical research at the American Venous Forum (AVF) 2026 Annual Meeting in Denver, Colorado. Her work, titled “VenaSeal™ Closure in Patients with Higher BMI,” was featured as part of the […]
Varicose veins are a common condition that affects up to 35% of the adult population in the United States. Varicose veins are enlarged, twisted, and bulging veins that usually occur in the legs and feet. They can be a cosmetic concern, but they can also cause discomfort, pain, and swelling. Fortunately, there are many treatment
How Long Will My Varicose Vein Treatments Last? Read More »
In the past, varicose veins were traditionally treated by a surgical procedure known as “vein stripping,” in which the veins were removed via surgical incisions while the patient was under general anesthesia. This was usually done at the hospital or surgery center. Thanks to advancements in medical treatment and technology, this is no longer the
What is the Least Painful Varicose Vein Treatment? Read More »
Now there are no downtime options to treat varicose veins in the office setting under a local anesthesia. The patient walks in, is treated, then walks out.
No Downtime Varicose Vein Treatments Read More »
Inovia Vein’s Dr. Andrew Jones, a noted pioneer in the clinical development of Venaseal for the treatment of varicose veins, traveled to India to help programs ready to implement Venaseal in their practices. Dr Jones and Dr. Edward Boyle were one of the first surgeons in the United States to test Venaseal before it was FDA
Dr. Jones Helps Introduce VenaSeal in India Read More »
Inovia Vein’s Dr. Edward Boyle spoke on a panel of experts on VenaSeal at the Venous Symposium in New York. The experts included Dr. Kathy Gibson, from Lake Washington Vascular in Seattle, and Dr. Leigh Ann O’Banion from the University of California San Francisco vascular surgery practice in Fresno, California. Together they discussed their clinical
Dr. Boyle on VenaSeal at the Venous Symposium Read More »
We are often asked if varicose vein treatment reduces risks of DVT. There is in fact evidence of this from patients having major orthopedic surgery. One of the biggest risks after major orthopedic surgery, such as a knee or hip replacement, is the development of a deep venous thrombosis (DVT) or pulmonary embolism (PE). Blood
Varicose Vein Treatment Reduces Risks of DVT Read More »
In recent years, Drs. Andrew Jones and Edward Boyle of the Inovia Vein Specialty Clinics participated as investigators in the Vecolse Trial. Our patients often ask us for an update on the published data as it becomes available. An update of this study appeared in the Journal of Vascular Surgery, Venous and Lymphatics Disorders this
Comparing Varicose Vein Treatments Read More »
INOVIA® Vein Specialty Center will be the first in Oregon to treat patients with venous reflux disease using the VenaSeal™ closure system. The VenaSeal™ closure system is a new, minimally invasive procedure that uses an advanced medical adhesive to close the diseased vein in patients with symptomatic venous reflux disease. Read the article released by The
INOVIA® first in Oregon to treat patients with VenaSeal Closure System Read More »
INOVIA® participated in the national Veclose trial, a randomized control trial comparing VenaSeal Sapheon Closure System with Radiofrequency Ablation (ClinicalTrials.gov Identifier:NCT01807585). Covidien today announced the six-month results of the VeClose pivotal study, which demonstrated the safety and effectiveness of the VenaSeal™ closure system* in patients with chronic venous insufficiency (CVI) having symptomatic reflux in the
Dr. Jones Presents VeClose Trial Data at the ACP Read More »
